Evidence map›Paper›PMID 38374064›Full record

ArticleNature communications2024

Cooperative Cu/azodiformate system-catalyzed allylic C-H amination of unactivated internal alkenes directed by aminoquinoline.

Le Wang, Cheng-Long Wang, Zi-Hao Li, Peng-Fei Lian, Jun-Chen Kang, Jia Zhou, Yu Hao, Ru-Xin Liu, He-Yuan Bai, Shu-Yu Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Le WangShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Cheng-Long WangShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Zi-Hao LiShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Peng-Fei LianShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Jun-Chen KangShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Jia ZhouShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Yu HaoShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Ru-Xin LiuShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
He-Yuan BaiShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China.ORCID http://orcid.org/0000-0002-8986-6913
Shu-Yu ZhangShanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, & Key Laboratory of Green and High-End Utilization of Salt Lake Resources, Shanghai Jiao Tong University, Shanghai, 200240, PR China. zhangsy16@sjtu.edu.cn.ORCID http://orcid.org/0000-0002-1811-4159
Shanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aliphatic allylic amines are common in natural products and pharmaceuticals. The oxidative intermolecular amination of C(sp

Identifiers

PMID38374064
PMCPMC10876528
OpenAlexW4391928819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.